October 30, 2018 Clinical Research/Diagn. Lab Top-10 Life Science Tools Product Launch

Illumina Launches TruSight Oncology 500 to Power Comprehensive, Accurate, Pan-Cancer Tumor Profiling

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announces the launch of TruSightTM Oncology 500 (TSO 500), a comprehensive pan-cancer assay designed to identify known and emerging tumor biomarkers. TruSight Oncology 500 utilizes both DNA and RNA from subject tumor samples to identify key somatic variants underlying tumor progression, such as small DNA variants, fusions, and... Read more

October 30, 2018 Clinical Research/Diagn. Life Science Tools Product Launch

Cofactor Genomics Launches ImmunoPrism™ Immune Profiling Kit, for Use in Clinical Sequencing Laboratories

October 30, 2018 08:00 ET | Source: Cofactor Genomics –Enables in-house, RNA-based, solid tumor profiling with powerful, cloud-based informatics tools to inform critical clinical decisions– SAN FRANCISCO, Oct. 30, 2018 (GLOBE NEWSWIRE) — Cofactor Genomics, a clinical RNA sequencing and translational assay developer, announced today the launch of a RNA-based immune profiling kit developed for laboratories wishing to derive... Read more

October 30, 2018 Lab Top-10 Licensing, IP, and Legal Life Science Tools

Agilent Sends Letter to the SEC Regarding Material Misstatements in Twist Bioscience’s S-1 Registration Statement

Agilent Sends Letter to the SEC Regarding Material Misstatements in Twist Bioscience’s S-1 Registration Statement SANTA CLARA, Calif., October 29, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it sent a letter to the Division of Corporation Finance of the U.S. Securities and Exchange Commission (SEC) regarding misstatements in the S-1 Registration Statement filed... Read more

October 29, 2018 Clinical Research/Diagn. Informatics & Software Life Science Tools

QIAGEN expands QIAGEN Clinical Insight software to support all major sequencing platforms and assay types

Hilden, Germany, and Germantown, Maryland, October 29, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of major enhancements to QIAGEN Clinical Insight (QCI) bioinformatics solutions to deliver expanded Sample to Insight workflows for clinical next-generation sequencing (NGS). QIAGEN introduced QCI Analyze Universal for full end-to-end workflow support of all... Read more

October 29, 2018 Atomic Spectroscopy Clinical Research/Diagn. Life Science Tools Microscopy

QIAGEN expands next-generation sequencing portfolio with oncology and immuno-oncology panels for research using GeneReader NGS System and other platforms 

Hilden, Germany, and Germantown, Maryland, October 29, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of three innovative Sample to Insight workflows for next-generation sequencing (NGS) research in oncology using QIAGEN’s GeneReader NGS System and other NGS platforms. QIAGEN is introducing the novel NGS workflows for clinical research in... Read more

October 23, 2018 Life Science Tools M&A, Partnerships

Lexogen supports thousands of RNA researchers worldwide by partnering with the RNA Society in their 2018/19 RNA Salon initiative

Vienna, Austria, October 23, 2018 /PRNewswire/ – RNA (ribonucleic acid) is one of the most important building blocks of life, and this molecule is researched in diverse biological disciplines. In 2016, the RNA Society launched the “RNA Salon” program to cultivate interactions between RNA researchers who might be regionally close but belong to various departments or... Read more

October 22, 2018 Environ, Ag./Food & Bev Informatics & Software Life Science Tools M&A, Partnerships

NRGene and Kayagene, LLC Collaborate to Improve Cannabis Breeding and Seed Production

Revealing the complete genome makeup of multiple varieties resolves the genetic basis of key traits Ness Ziona, Israel, and Salinas, Calif. (Oct 22, 2018)– Kayagene, an innovative cannabis breeding company, and NRGene, the leading agricultural genomics company, are collaborating on research to enhance Kayagene’s breeding capabilities  to develop improved cannabis varieties and more robust seed production. The non-exclusive... Read more

October 18, 2018 Life Science Tools PR/Corporate

Amgen invests £50 million ($66 million) in Oxford Nanopore Technologies

Thu 18th October 2018 THOUSAND OAKS, Calif. and OXFORD, England – (Oct. 18, 2018) – Amgen (NASDAQ:AMGN) and Oxford Nanopore Technologies Ltd. today announced Amgen’s equity investment of £50 million ($66 million) in Oxford Nanopore, a privately-owned, UK-based company advancing a new generation of portable, real-time genetic sequencing technology. Oxford Nanopore has developed and brought to... Read more

October 18, 2018 Life Science Tools

LGC announces new name for integrated genomics brand, Biosearch Technologies

18 OCT 2018 Tags:  Genomics LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes. Biosearch Technologies will focus on further developing its capabilities in NGS and Nucleic Acid Chemistry, which build on expertise in existing genomic analysis... Read more

October 18, 2018 Informatics & Software Life Science Tools M&A, Partnerships

Fabric Genomics and Genomenon Sign Partnership Agreement to Speed Genomic Interpretation

Partnership will improve access to critical literature content and accelerate patient diagnosis OAKLAND, Calif. and ANN ARBOR, Michigan, October 18, 2018 – Fabric Genomics™, a global leader in clinical interpretation of genomic data, and Genomenon®, the leading genomic data search company, announced today that they have entered into a partnership with the goal of further... Read more